Imaging-Based Risk Stratification for Recurrence Risk in Women with a History of Peripartum Cardiomyopathy

Abstract

Objective Peripartum cardiomyopathy (PPCM) affects 1:1,000 U.S. pregnancies, and while many recover from the disease, the risk of recurrence in subsequent pregnancy (SSP) is high. This study aims to evaluate the utility of left ventricular ejection fraction (LVEF) and global longitudinal strain (GLS) to predict the risk of recurrence of PPCM in SSP.

Study Design We retrospectively evaluated outcomes in women with a history of PPCM and SSP at a large-volume cardioobstetrics program (2008–2019).

Results There were 18 women who had incident PPCM and pursued SSP. Of 24 pregnancies in these women, 8 (33%) were complicated by the development of recurrent PPCM. LVEF ≥ 52% or GLS ≤ −16 was associated with a low risk of recurrent PPCM.

Conclusion Approximately one-third of women with PPCM developed recurrent PPCM in SSP. LVEF and GLS on prepregnancy echocardiography may predict the risk of recurrence. Additional studies evaluating risk for recurrence are required to better understand which women are the safest to consider SSP.

Key Points

1. Peripartum cardiomyopathy affects 1:1000 US pregnancies.

2. Approximately one third of women with a history of peripartum cardiomyopathy developed recurrent disease in a subsequent pregnancy.

3. A left ventricular ejection fraction ≥52% or global longitudinal strain ≤−16 on echocardiogram is associated with a low risk of recurrence.

Keywords

peripartum - cardiomyopathy - strain - ejection fraction

Publikationsverlauf

Eingereicht: 11. November 2020

Angenommen: 04. Oktober 2021

Artikel online veröffentlicht:
02. Dezember 2021

• References

• 1 Sliwa K, Hilfiker-Kleiner D, Petrie MC. et al; Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 2010; 12 (08) 767-778
• 2 Pearson GD, Veille JC, Rahimtoola S. et al. Peripartum cardiomyopathy: national heart, lung, and blood institute and office of rare diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000; 283 (09) 1183-1188
• 3 Davis MB, Arany Z, McNamara DM, Goland S, Elkayam U. Peripartum cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol 2020; 75 (02) 207-221
• 4 Kolte D, Khera S, Aronow WS. et al. Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J Am Heart Assoc 2014; 3 (03) e001056
• 5 Sliwa K, Petrie MC, Hilfiker-Kleiner D. et al. Long-term prognosis, subsequent pregnancy, contraception and overall management of peripartum cardiomyopathy: practical guidance paper from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy. Eur J Heart Fail 2018; 20 (06) 951-962
• 6 Pearl W. Familial occurrence of peripartum cardiomyopathy. Am Heart J 1995; 129 (02) 421-422
• 7 Guldbrandt Hauge M, Johansen M, Vejlstrup N, Gustafsson F, Damm P, Ersbøll AS. Subsequent reproductive outcome among women with peripartum cardiomyopathy: a nationwide study. BJOG 2018; 125 (08) 1018-1025
• 8 Elkayam U, Tummala PP, Rao K. et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001; 344 (21) 1567-1571
• 9 Elkayam U. Risk of subsequent pregnancy in women with a history of peripartum cardiomyopathy. J Am Coll Cardiol 2014; 64 (15) 1629-1636
• 10 Thavendiranathan P, Poulin F, Lim KD, Plana JC, Woo A, Marwick TH. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol 2014; 63 (25, pt. A): 2751-2768
• 11 Witkowski TG, Thomas JD, Debonnaire PJMR. et al. Global longitudinal strain predicts left ventricular dysfunction after mitral valve repair. Eur Heart J Cardiovasc Imaging 2013; 14 (01) 69-76
• 12 Kearney LG, Lu K, Ord M. et al. Global longitudinal strain is a strong independent predictor of all-cause mortality in patients with aortic stenosis. Eur Heart J Cardiovasc Imaging 2012; 13 (10) 827-833
• 13 Fett JD, Christie LG, Murphy JG. Brief communication: outcomes of subsequent pregnancy after peripartum cardiomyopathy: a case series from Haiti. Ann Intern Med 2006; 145 (01) 30-34
• 14 Lang RM, Badano LP, Mor-Avi V. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015; 28 (01) 1-39.e14
• 15 Menting ME, McGhie JS, Koopman LP. et al. Normal myocardial strain values using 2D speckle tracking echocardiography in healthy adults aged 20 to 72 years. Echocardiography 2016; 33 (11) 1665-1675
• 16 Yang H, Wright L, Negishi T, Negishi K, Liu J, Marwick TH. Research to practice: assessment of left ventricular global longitudinal strain for surveillance of cancer chemotherapeutic-related cardiac dysfunction. JACC Cardiovasc Imaging 2018; 11 (08) 1196-1201
• 17 Gustafsson F, Torp-Pedersen C, Seibaek M, Burchardt H, Køber L. DIAMOND study group. Effect of age on short and long-term mortality in patients admitted to hospital with congestive heart failure. Eur Heart J 2004; 25 (19) 1711-1717
• 18 Vaught AJ, Kovell LC, Szymanski LM. et al. Acute cardiac effects of severe pre-eclampsia. J Am Coll Cardiol 2018; 72 (01) 1-11